13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
Live feed/ Filings/ SCHEDULE 13G/ 0001862953-26-000003
SCHEDULE 13G Filed 2026-07-02 Event — SEC 0001862953-26-000003 →

SHERPA HEALTHCARE FUND II, L.P. → Alamar Biosciences, Inc. ALMR

Stake: — Shares: — CUSIP: 010911105 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
86 transactions
12 buys · 0 sales · 0 awards/exercises
Issuer Cluster
4 13D/G filings on this issuer
3 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-07-31
DTC 11.32
2,430,004 shares short · +8.2% vs prior

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-04-20 Qiming Corporate GP VI, Ltd. 10%+ owner C 185,163 — —
2026-04-20 Illumina Innovation Fund II GP, L.L.C. 10%+ owner C 4,588,364 — —
2026-04-20 Chambers Rebecca director J 140,612 $7.60 $1.07M
2026-04-20 Witney Frank director J 49,627 $0.59 $29K
2026-04-20 White Timothy Ogden officer J 454,583 — —
2026-04-20 Chen Shiping director, officer C 320,511 — —
2026-04-20 Luo Yuling director, officer C 1,386,746 — —
2026-04-20 McAnear Justin J. officer Award 37,220 — —
2026-04-20 Naclerio Nicholas director C 4,588,364 — —
2026-04-20 Illumina Innovation Fund II GP, L.L.C. 10%+ owner C 922,152 — —
2026-04-20 Illumina Innovation Fund II GP, L.L.C. 10%+ owner J 5,510,516 — —
2026-04-20 Illumina Innovation Fund II GP, L.L.C. 10%+ owner C 346,020 — —
2026-04-20 Illumina Innovation Fund II GP, L.L.C. 10%+ owner C 271,782 — —
2026-04-20 Illumina Innovation Fund II GP, L.L.C. 10%+ owner Buy 235,294 $17.00 $4.00M
2026-04-20 Illumina Innovation Fund II GP, L.L.C. 10%+ owner C 3,194,377 — —
2026-04-20 Illumina Innovation Fund II GP, L.L.C. 10%+ owner C 2,862,507 — —
2026-04-20 Illumina Innovation Fund II GP, L.L.C. 10%+ owner C 2,094,266 — —
2026-04-20 Illumina Innovation Fund II GP, L.L.C. 10%+ owner C 5,037,783 — —
2026-04-20 Illumina Innovation Fund II GP, L.L.C. 10%+ owner C — — —
2026-04-20 Qiming Corporate GP VI, Ltd. 10%+ owner C 6,881,410 — —
2026-04-20 Qiming Corporate GP VI, Ltd. 10%+ owner C 1,605,645 — —
2026-04-20 Qiming Corporate GP VI, Ltd. 10%+ owner C 1,922,329 — —
2026-04-20 Qiming Corporate GP VI, Ltd. 10%+ owner J 185,163 — —
2026-04-20 Qiming Corporate GP VI, Ltd. 10%+ owner J 6,881,410 — —
2026-04-20 Qiming Corporate GP VI, Ltd. 10%+ owner J 1,605,645 — —
Showing 25 of 86

Other 13D/G Filings on Alamar Biosciences, Inc.

FiledFormFilerStakeShares
2026-07-07 SCHEDULE 13D/A Sands Capital Life Sciences Pulse Fund II, L.P. 6.10% 4,230,926 view →
2026-04-23 SCHEDULE 13D Illumina Innovation Fund II, L.P. 9.60% 5,856,536 view →
2026-04-23 SCHEDULE 13D Sands Capital Life Sciences Pulse Fund II, L.P. 6.30% 4,230,926 view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →